Argent Capital Management’s Edwards Lifesciences EW Stock Holding History

Argent Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Hold	14,080	–	–	0.04%	108
2026 Q1	$1.13M	Hold	14,080	–	–	0.04%	113
2025 Q4	$1.2M	Hold	14,080	–	–	0.03%	102
2025 Q3	$1.1M	Hold	14,080	–	–	0.03%	101
2025 Q2	$1.1M	Hold	14,080	–	–	0.03%	99
2025 Q1	$1.02M	Hold	14,080	–	–	0.03%	101
2024 Q4	$1.04M	Sell	14,080 -2,120	-13%	-$148K	0.03%	105
2024 Q3	$1.07M	Sell	16,200 -856	-5%	-$62.2K	0.03%	97
2024 Q2	$1.58M	Hold	17,056	–	–	0.05%	88
2024 Q1	$1.63M	Sell	17,056 -113	-0.7%	-$9.49K	0.05%	88
2023 Q4	$1.31M	Hold	17,169	–	–	0.04%	91
2023 Q3	$1.19M	Hold	17,169	–	–	0.04%	92
2023 Q2	$1.62M	Hold	17,169	–	–	0.05%	92
2023 Q1	$1.42M	Buy	17,169 +969	+6%	+$76.2K	0.05%	96
2022 Q4	$1.21M	Hold	16,200	–	–	0.04%	99
2022 Q3	$1.34M	Hold	16,200	–	–	0.05%	100
2022 Q2	$1.54M	Hold	16,200	–	–	0.06%	95
2022 Q1	$1.91M	Hold	16,200	–	–	0.06%	94
2021 Q4	$2.1M	Hold	16,200	–	–	0.06%	92
2021 Q3	$1.83M	Hold	16,200	–	–	0.06%	94
2021 Q2	$1.68M	Hold	16,200	–	–	0.05%	99
2021 Q1	$1.35M	Hold	16,200	–	–	0.05%	104
2020 Q4	$1.48M	Hold	16,200	–	–	0.05%	103
2020 Q3	$1.29M	Hold	16,200	–	–	0.05%	118
2020 Q2	$1.12M	Hold	16,200	–	–	0.05%	125
2020 Q1	$1.02M	Buy	+16,200	New	+$1.17M	0.05%	123

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Argent Capital Management's EW Position: Q2 2026 in Review

Argent Capital Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 14,080 shares worth $1.27M. The position accounts for 0.04% of the portfolio, ranked #108.

Argent Capital Management first reported a position in EW in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.1M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Argent Capital Management held 14,080 shares of Edwards Lifesciences worth $1.27M as of Q2 2026.
Argent Capital Management left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.04% of Argent Capital Management's portfolio in Q2 2026, its #108 holding.
Argent Capital Management first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 26 quarters since.
Argent Capital Management's Edwards Lifesciences position peaked at $2.1M in Q4 2021.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Argent Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.